Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Gains from Investment Securities: 2015-2024

Historic Gains from Investment Securities for Anaptysbio (ANAB) over the last 7 years, with Dec 2024 value amounting to $7.5 million.

  • Anaptysbio's Gains from Investment Securities fell 46.08% to -$22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.0 million, marking a year-over-year decrease of 2.23%. This contributed to the annual value of $7.5 million for FY2024, which is N/A change from last year.
  • As of FY2024, Anaptysbio's Gains from Investment Securities stood at $7.5 million, which was down 63.72% from $20.7 million recorded in FY2021.
  • Anaptysbio's Gains from Investment Securities' 5-year high stood at $20.7 million during FY2021, with a 5-year trough of $7.5 million in FY2024.
  • Its 1-year average for Gains from Investment Securities is $7.5 million, with a median of $7.5 million in 2024.